Merino, D
Lok, S W
Visvader, J E
Lindeman, G J
Article History
Received: 13 April 2015
Revised: 26 May 2015
Accepted: 8 June 2015
First Online: 10 August 2015
Competing interests
: DM, JEV and GJL are employees of The Walter and Eliza Hall Institute, which receives commercial income and research funding from Genentech and AbbVie, and also collaborates with and receives research funding from Servier. The Royal Melbourne Hospital (Melbourne Health) will receive research funds from AbbVie for an investigator-initiated study on ABT-199 in breast cancer (ISRCTN98335443) where GJL is lead investigator and SWL and JEV are co-investigators. GJL has served on an Advisory Board for AbbVie and Genentech.